Cannex

Starpharma Holdings, located in South Yarra, VIC, is an innovative biotechnology company specializing in dendrimer technology aimed at improving health outcomes for patients, particularly those suffering from significant illnesses such as cancer. With over two decades of experience, Starpharma focuses on advancing their proprietary drug delivery platform, DEP, which enhances the effectiveness of various pharmaceutical drugs across multiple therapeutic areas. The company has established a robust pipeline of oncology products and has successfully commercialized several products based on their unique dendrimer, SPL7013, which possesses antiviral and antimicrobial properties. Through strategic partnerships with global industry leaders, Starpharma is well-positioned to address critical clinical needs and drive advancements in patient care. Generated from the website